Q3 saw a 6.6% sales decline, but gross margin and EBIT improved due to cost savings and a favorable mix. Major one-time costs included a SEK 265 million impairment and SEK 27 million write-down, while OEM growth and restructuring initiatives support a positive outlook for 2025.
Based on
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.
